Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657119 · ClinicalTrials.gov registry record · NA
Family Safety Net - Aim 3: Randomized Control Trial
A NA study of Suicide and Firearm Injury, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT05657119: Active NA study of Suicide and Firearm Injury, sponsored by University of Michigan.
NCT05657119 is a NA study of Suicide and Firearm Injury that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 86 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657119, a NA study of Suicide and Firearm Injury, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
Our parallel group clinical trial of the Family Safety Net (FSN) intervention addresses two main questions: * Is the Family Safety Net (FSN) intervention feasible and acceptable in two formats: motivational interviewing (FSN MI) counseling session and scripted psychoeducational session (FSN Scripted), with a primarily Alaska Native population in Northwest Alaska? * Secondarily, are there signals of efficacy at improving home safety (firearms unloaded, locked with ammunition separate) and dangerous medication locked? All participants will complete a baseline survey with firearm storage questions as well as 3 questions about mental health concerns in their family (e.g. 'Are you worried that someone in your home is at risk of suicide?'). * If participants answer "yes" to any of these questions, they will be randomly assigned to one of the two FSN intervention groups (1 and 2 below). * If they do not endorse any of the three family-focused mental health questions, they will be randomly assigned to one of two general firearm safety conditions (3 and 4 below). 1. FSN MI group will participate in a 15-20-minute motivational interviewing (MI) session conducted by trained research staff focused on suicide lethal means reduction. 2. FSN Scripted group will participate in a 10-minute scripted session focused on suicide lethal means reduction. Both FSN groups (1 and 2): * Can take home trigger locks, cable locks, ammo boxes, medication boxes and mental health resources * Receive 4 weeks of tailored text message reminders and encouragement. * Complete 1-month follow-up survey consisting of items related to firearm storage, and facilitating factors hypothesized to contribute to this behavior. * Participants in both FSN conditions will be invited to participate in a semi-structured interview at follow-up focused on satisfaction and perceptions of the program. 3 General gun safety intervention group will participate in a 10-minute scripted conversation about safe gun s
Primary Outcome
Feasibility was measured by examining the number of people who met eligibility criteria and chose to participate in the study. This basic process measure allowed us to assess the scope and scalability of the FSN intervention.
Conditions Studied
Interventions
- BEHAVIORAL MI FSN - Lethal Means Reduction
- BEHAVIORAL Scripted FSN - Lethal Means Reduction
- BEHAVIORAL General Firearm Safety Intervention - General Firearm Safety
- BEHAVIORAL General Firearm Comparison - General Firearm Safety
Study Locations (1)
Alaska
- Maniilaq Association - Kotzebue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What the registry record for NCT05657119 still lists
NCT05657119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 4 interventions - of which MI FSN - Lethal Means Reduction is the first listed.
NCT05657119 reports a single indexed study location in Alaska.
Frequently Asked Questions
What is clinical trial NCT05657119 about?
NCT05657119 is a clinical study titled "Family Safety Net - Aim 3: Randomized Control Trial". Our parallel group clinical trial of the Family Safety Net (FSN) intervention addresses two main questions: * Is the Family Safety Net (FSN) intervention feasible and acceptable in two formats: motivational interviewing (FSN MI) counseling session and scripted psychoeducational session (FSN Scripte...
What is the current status of trial NCT05657119?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2022-11-02. Estimated completion is 2025-12-30.
What conditions does trial NCT05657119 study?
This clinical trial studies the following conditions: Suicide, Firearm Injury, Accidental Injuries.
What interventions are being tested in trial NCT05657119?
The interventions under investigation include: MI FSN - Lethal Means Reduction (BEHAVIORAL), Scripted FSN - Lethal Means Reduction (BEHAVIORAL), General Firearm Safety Intervention - General Firearm Safety (BEHAVIORAL), General Firearm Comparison - General Firearm Safety (BEHAVIORAL).
Who is sponsoring clinical trial NCT05657119?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05657119 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05657119's enrollment target sits among peer trials
86 53rd of 92 higher than 40 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI